AIFarm Competitors

Pink Sheets . USA . 
Stock . AIFarm
AIFM Stock  USD 0  0  200.00%   
AIFarm competes with Dave Busters, Coinbase Global, Glacier Bancorp, Artisan Partners, and Sonos; as well as few others. The company conducts business under Industrials sector and is part of Farm & Heavy Construction Machinery industry. Analyzing AIFarm competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AIFarm to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out AIFarm Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AIFarm competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00050.15
Details
Intrinsic
Valuation
LowRealHigh
0.00050.15
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
000
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AIFarm. Your research has to be compared to or analyzed against AIFarm's peers to derive any actionable benefits. When done correctly, AIFarm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AIFarm.

AIFarm Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AIFarm and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of AIFarm and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AIFarm does not affect the price movement of the other competitor.

High positive correlations

SPHR
+ 0.91
COIN
ASO
+ 0.87
APAM
APAM
+ 0.84
GBCI
ASO
+ 0.84
GBCI
APAM
+ 0.8
COIN
ASO
+ 0.79
SPHR
  

High negative correlations

UBSFF
- 0.66
APAM
UBSFF
- 0.58
COIN
UBSFF
- 0.56
PLAY
UBSFF
- 0.54
ASO
UBSFF
- 0.53
SPHR
UBSFF
- 0.38
GBCI

Risk-Adjusted Indicators

There is a big difference between AIFarm Pink Sheet performing well and AIFarm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AIFarm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

AIFarm Competitive Analysis

The better you understand AIFarm competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AIFarm's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AIFarm's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AIFM PLAY COIN GBCI APAM SONO SPHR ASO UBSFF
 200.00 
 0 
AIFarm
 1.58 
 25.58 
Dave
 2.26 
 317.55 
Coinbase
 1.62 
 45.41 
Glacier
 2.93 
 46.39 
Artisan
 1.67 
 12.96 
Sonos
 1.24 
 39.87 
Sphere
 1.44 
 54.02 
Academy
 2.17 
 10.82 
Ubisoft
Market Volatility
(90 Days Market Risk)
Out of control
Not too volatile
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Not too volatile
Market Performance
(90 Days Performance)
Fair
Mild
Fair
Mild
Fair
Fair
Weak
Fair
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Strong
Small
Tiny
Low
Low
Low
Fair
Low
Small
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Buy
Hold
Buy
Buy
Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Hold
Strong Hold
Hold
Strong Sell
Hold
Strong Hold
Strong Sell
Current Ratio
0.03
0.53
1.05
N/A
1.48
1.83
N/A
1.58
1.49
Net Asset
88.27 K
4.02 B
22.54 B
27.9 B
1.62 B
916.31 M
4.79 B
4.9 B
4.96 B
Profit Margin
N/A
0.0183
0.43
0.26
0.24
-0.0541
-0.29
0.0655
-0.0532
EBITDA
(487.13 K)
443.4 M
3.15 B
267.97 M
449.41 M
25.67 M
(23.86 M)
693.17 M
888.4 M
Current Valuation
676.83 K
4.1 B
78.34 B
8.07 B
3.35 B
1.43 B
2.08 B
5.19 B
4.24 B
Operating Margin
N/A
0.12
0.14
0.35
0.28
-0.0028
-0.16
0.0513
0.0762
Price To Book
N/A
6.12
6.9
1.55
8.82
4.05
0.61
1.87
1.9
Retained Earnings
N/A
657.5 M
4.96 B
1.08 B
170.04 M
(50.93 M)
11.39 M
1.76 B
(66 M)
Current Asset
N/A
110.08 M
498 K
N/A
234.61 M
241.18 M
N/A
N/A
1.13 B
Five Year Return
N/A
N/A
N/A
2.49
8.1
N/A
N/A
N/A
N/A
Beta
-0.31
2.15
3.71
0.79
1.67
2.04
1.71
1.3
0.0788
Number Of Employees
3
23.42 K
3.77 K
3.67 K
584
1.71 K
1.08 K
22 K
20.73 K
Shares Outstanding
676.83 K
34.58 M
215.16 M
118.55 M
70.47 M
120.88 M
29.13 M
66.48 M
125.08 M
Cash Flow From Operations
(590.9 K)
312.3 M
2.56 B
258.04 M
372.84 M
189.91 M
(19.66 M)
528.08 M
705.7 M
Annual Yield
N/A
N/A
N/A
0.0286
0.0642
N/A
N/A
0.0094
N/A
Total Debt
54.73 K
3.14 B
4.32 B
3.79 B
300.71 M
64.14 M
1.52 B
1.79 B
1.13 B
Return On Equity
N/A
0.18
0.28
0.066
0.58
-0.18
-0.16
0.2
-0.0635
Z Score
-9.3
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.2
Return On Asset
-3.28
0.0349
0.0076
0.0078
0.16
-0.0347
-0.0262
0.062
0.0205
Book Value Per Share
-2.73
4.25
47.17
29.8
5.42
3.31
64.27
29.3
14.29
Number Of Shares Shorted
N/A
5.98 M
10.27 M
1.65 M
3.14 M
7.1 M
7.47 M
7.13 M
N/A
Current Liabilities
N/A
156.65 M
3.49 M
N/A
629.98 M
50.71 M
N/A
N/A
527 M
Total Asset
88.27 K
4.02 B
22.54 B
27.9 B
1.62 B
916.31 M
4.79 B
4.9 B
4.96 B
Debt To Equity
N/A
8.11
0.65
7.44
0.86
0.056
N/A
1.22
1.14
Short Ratio
N/A
6.43
0.78
4.9
5.42
3.99
12.23
4.93
N/A
Target Price
N/A
33.0
365.98
50.33
45.63
13.63
53.9
55.61
3.95
Last Dividend Paid
N/A
N/A
N/A
1.32
3.07
N/A
N/A
0.48
N/A
Shares Owned By Institutions
N/A
97.81
60.74
81.41
91.2
92.27
94.24
98.45
47.65
Market Capitalization
676.83 K
898.63 M
83.48 B
5.47 B
3.37 B
1.59 B
1.42 B
3.64 B
2.84 B
Price To Earning
N/A
14.38
4.53
17.81
8.34
48.75
N/A
7.67
69.37
Price To Earnings To Growth
N/A
1.48
11.96
2.1
1.38
-3.53
N/A
0.72
1.7
Price To Sales
N/A
0.43
12.45
6.4
2.96
1.13
1.36
0.62
1.69
Net Income
(547.09 K)
58.3 M
2.58 B
190.14 M
349.65 M
(38.15 M)
(200.65 M)
418.45 M
79.1 M
Earnings Per Share
-0.97
1.09
10.36
1.93
3.78
-0.62
-9.79
5.4
0.68
Shares Owned By Insiders
50.61
2.19
1.95
0.8
2.69
2.48
5.76
1.55
28.55
Revenue
N/A
2.13 B
6.56 B
1.25 B
1.11 B
1.52 B
1.03 B
5.93 B
2.13 B
Working Capital
N/A
(339.5 M)
10.17 B
N/A
(91.99 M)
184.93 M
(507.98 M)
749.27 M
603 M
Cash And Equivalents
88.27 K
100.39 M
5.01 B
425.21 M
163.29 M
439.73 M
N/A
399.86 M
1.45 B
Cash Per Share
0.13
2.08
22.07
3.84
2.42
3.46
N/A
5.01
11.83
Gross Profit
N/A
869.5 M
5.67 B
855.05 M
518.43 M
611.18 M
448.86 M
2.01 B
1.86 B
Day Typical Price
0.003
25.88
318.5
45.62
46.59
13.07
39.7
54.17
10.8
Accumulation Distribution
N/A
32482.62
214918.0
14802.23
16327.07
71906.93
12215.4
14992.25
0.0055
Market Facilitation Index
N/A
0.0
0.0
0.0
0.0
N/A
0.0
0.0
0.06
Daily Balance Of Power
9.2 T
(0.32)
(0.83)
(0.62)
(1.16)
(0.54)
0.5213
(0.81)
3.833333
Period Momentum Indicator
0.002
(0.41)
(7.34)
(0.75)
(1.40)
(0.22)
0.49
(0.79)
0.23
Rate Of Daily Change
3.0
0.98
0.98
0.98
0.97
0.98
1.01
0.99
1.02
Day Median Price
0.003
26.04
318.98
45.72
46.69
13.13
39.62
54.25
10.79
Price Action Indicator
0.001
(0.66)
(5.10)
(0.69)
(0.99)
(0.27)
0.49
(0.62)
0.15
Relative Strength Index
66.67
3.59
80.42
40.62
54.38
36.14
57.81
87.61
31.9
Coefficient Of Variation
812.41
1337.18
655.65
1986.98
547.02
738.23
1433.75
889.91
(1,163)
Mean Deviation
1986.61
3.37
3.49
1.55
1.31
2.23
1.98
1.91
1.2
Jensen Alpha
1081.05
0.1313
0.7189
(0.06)
0.2946
0.443
0.012
0.1017
(0.22)
Total Risk Alpha
103.12
(0.18)
0.2162
(0.12)
0.1058
0.0684
(0.12)
(0.01)
(0.46)
Sortino Ratio
N/A
0.071
0.1751
0.0035
0.1345
0.1315
0.0329
0.0837
N/A
Downside Variance
N/A
13.22
17.45
3.59
2.29
6.54
7.59
5.73
N/A
Standard Deviation
8193.85
4.65
5.38
1.91
1.6
3.14
2.58
2.58
2.31
Kurtosis
66.0
2.21
6.45
0.3215
(0.15)
3.8
0.5524
0.369
5.45
Potential Upside
N/A
9.17
9.01
2.76
2.22
4.92
3.44
5.24
2.71
Treynor Ratio
(1.11)
0.13
0.6993
0.0459
(1.89)
(1.20)
0.0854
0.1247
(1.11)
Maximum Drawdown
66666.57
25.55
40.67
10.48
7.64
13.87
12.74
11.03
11.59
Variance
6.71391132E7
21.59
28.98
3.65
2.56
9.87
6.66
6.65
5.32
Market Risk Adjusted Performance
(1.10)
0.14
0.7093
0.0559
(1.88)
(1.19)
0.0954
0.1347
(1.10)
Risk Adjusted Performance
0.0984
0.0622
0.1183
0.0424
0.1369
0.105
0.0573
0.088
(0.05)
Skewness
8.12
1.11
1.18
(0.02)
0.044
1.12
(0.32)
0.3652
(0.09)
Semi Deviation
N/A
3.38
3.71
1.84
1.25
2.39
2.63
2.14
N/A
Information Ratio
0.1231
0.0555
0.1359
0.0035
0.127
0.107
0.0351
0.0777
(0.12)
Value At Risk
N/A
(6.50)
(5.77)
(2.89)
(2.38)
(4.16)
(3.91)
(3.66)
(4.33)
Expected Short fall
N/A
(3.92)
(4.23)
(1.64)
(1.45)
(2.58)
(2.00)
(2.02)
N/A
Downside Deviation
N/A
3.64
4.18
1.9
1.51
2.56
2.76
2.39
N/A
Semi Variance
N/A
11.44
13.8
3.38
1.57
5.69
6.9
4.56
N/A

AIFarm Competition Performance Charts

Five steps to successful analysis of AIFarm Competition

AIFarm's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AIFarm in relation to its competition. AIFarm's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AIFarm in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AIFarm's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AIFarm, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AIFarm position

In addition to having AIFarm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Commodities ETFs Thematic Idea Now

Broad Commodities ETFs
Broad Commodities ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AIFarm Pink Sheet

AIFarm financial ratios help investors to determine whether AIFarm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AIFarm with respect to the benefits of owning AIFarm security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY